Follow Your Heart
This young patient could be classified as having unfavorable early-stage Hodgkin lymphoma (HL) per the European Organization for Research and Treatment of Cancer H10 study or advanced HL per UK Response-Adapted Therapy for Advanced Hodgkin Lymphoma study, both adaptive therapy trials commencing with 2 cycles of Doxorubicin, bleomycin, vinblastine, and dacarbazine.1
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Bradford S. Hoppe Tags: Gray Zone Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Cardiology | Heart | Lymphoma | Physics | Radiology | Study